FDA announced Thursday the availability of an additional million doses of FluMist and its plans for an abbreviated process to approve and import foreign flu vaccines. MedImmune (MEDI) will increase its FluMist
Read the full 329 word article
User Sign In
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury